IBM Accelerates Enterprise Gen AI Revolution with Hybrid Capabilities

Go back to IBM Accelerates Enterprise Gen AI Revolution with Hybrid Capabilities

Morgan Stanley Reiterates Equalweight Rating on IBM (IBM)

May 7, 2025 6:30 AM EDT

Morgan Stanley analyst Erik Woodring reiterated an Equalweight rating and $233.00 price target on IBM (NYSE: IBM)

The analyst comments "IBM Think 2025 - The Year of Agentic AI. IDC estimates that 1B new applications will be created by 2028 due to GenAI innovations, with these apps leveraging... More